Merck starts recruitment for Covid-19 vaccine human trial

Earlier this month, Chief Executive Officer Kenneth Frazier had said the company aims to start human trials on one of its Covid-19 vaccine candidates “fairly soon,” with a second vaccine candidate likely to begin trials later this year.
The study is based in Belgium and aims to recruit 260 participants.(REUTERS)
The study is based in Belgium and aims to recruit 260 participants.(REUTERS)
Published on Sep 12, 2020 05:43 AM IST
Copy Link
Reuters | ByReuters| Posted by Susmita Pakrasi

US drugmaker Merck & Co Inc has begun recruiting participants to its early-stage Covid-19 vaccine study, according to the government database clinicaltrials.gov.

The study is based in Belgium and aims to recruit 260 participants. The WSJ first reported the news.

Earlier this month, Chief Executive Officer Kenneth Frazier had said the company aims to start human trials on one of its Covid-19 vaccine candidates “fairly soon,” with a second vaccine candidate likely to begin trials later this year.

SHARE THIS ARTICLE ON
Close Story
QUICKREADS

Less time to read?

Try Quickreads

  • Rubble covers where the field kitchen stood outside of the Donetsk Academic Regional Drama Theatre on March 17, 2022, in Mariupol, Ukraine. 

    This country will train Ukrainian military on landmine removal

    A team of Colombian soldiers will travel to Europe to train their Ukrainian counterparts on de-mining techniques, the South American country's defense minister said on Monday. Colombia's nearly 60 years of internal conflict between the armed forces, leftist rebels, right-wing paramilitaries and drug cartels has made it one of the world's most-mined countries, according to the United Nations.

  • Workers in protective suits stand at a closed residential area during lockdown, amid the coronavirus disease (COVID-19) outbreak, in Shanghai, China, May 23, 2022. REUTERS/Aly Song

    Why Shanghai lockdown is on despite ease in curbs? 10 global Covid updates

    In Chinese financial hub of Shanghai, which has been struggling to tackle the spread of coronavirus, neighbourhood committees in the city are now imposing strict and arbitrary curbs on movement of residents, including restrictions and time-limit on who can leave their apartment blocks and for how long - even as the authorities are lifting the lockdown as cases dip, a report by Bloomberg highlighted. Here are top updates on global Covid-19 situation 1.

  • Quad Summit leader Australia’s Prime Minister Anthony Albanese is pictured at Kantei Palace in Tokyo, Japan.

    Australia PM says goals aligned with Quad, wants to discuss climate change

    New Australian Prime Minister Anthony Albanese on Tuesday said his goals were aligned with the priorities of the Quad grouping of countries, telling the leaders of the United States, India and Japan that he wanted to also discuss climate change. Albanese, the leader of Australia's Labor Party who was sworn in as his country's 31st prime minister a day earlier, also said the Quad stood together for a "free and open Indo-Pacific".

  • US President Joe Biden meets Quad Summit leaders in Tokyo, Japan.

    'Putin trying to erase a culture...': Biden on Ukraine, global food crisis

    Calling the invasion of Ukraine a “global issue”, US President Joe Biden on Tuesday said that his Russian counterpart, Vladimir Putin, is trying to “extinguish a culture”. During his opening remarks at the Quad Summit in Tokyo, Biden warned that the global food crisis could worsen if Russia continues blocking Ukraine from exporting its grains. Biden stressed that the US will be a strong, steady and enduring partner in the region.

  • Dr. Mayank Amin administers a Pfizer-BioNTech Covid-19 booster vaccine to 10-year-old Ernest "EJ" Jones in Schwenksville, Pennsylvania.

    Pfizer says 3 Covid shots protect children under 5

    Three doses of Pfizer's Covid-19 vaccine offer strong protection for children younger than 5, the company announced Monday, another step toward shots for the littlest kids possibly beginning in early summer. Pfizer plans to submit the findings to U.S. regulators later this week. The 18 million youngsters under 5 are the only group in the U.S. not yet eligible for Covid-19 vaccination. Pfizer has had a bumpy time figuring out its approach.

SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Tuesday, May 24, 2022